Influence of anxiety on health outcomes in COPD

被引:205
作者
Eisner, Mark D. [1 ,2 ]
Blanc, Paul D. [1 ,2 ]
Yelin, Edward H. [3 ]
Katz, Patricia P. [3 ]
Sanchez, Gabriela [4 ]
Iribarren, Carlos [4 ]
Omachi, Theodore A. [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, Div Occupat & Environm Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA
[4] Kaiser Permanente, Div Res, Oakland, CA USA
基金
美国国家卫生研究院;
关键词
OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; HOSPITAL ANXIETY; SALMETEROL/FLUTICASONE PROPIONATE; FUNCTIONAL LIMITATION; EXERCISE CAPACITY; DEPRESSION SCALE; BODE INDEX; TIOTROPIUM; RISK;
D O I
10.1136/thx.2009.126201
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Psychological functioning is an important determinant of health outcomes in chronic lung disease. To better define the role of anxiety in chronic obstructive pulmonary disease (COPD), a study was conducted of the inter-relations between anxiety and COPD in a large cohort of subjects with COPD and a matched control group. Methods Data were used from the FLOW (Function, Living, Outcomes, and Work) cohort of patients with COPD (n=1202) and matched controls without COPD (n=302). Anxiety was measured using the Anxiety subscale of the Hospital Anxiety and Depression Scale. Results COPD was associated with a greater risk of anxiety in multivariable analysis (OR 1.85; 95% CI 1.072 to 3.18). Among patients with COPD, anxiety was related to poorer health outcomes including worse submaximal exercise performance (less distance walked during the 6-min walk test: -66.3 feet for anxious vs non-anxious groups; 95% CI -127.3 to -5.36) and a greater risk of self-reported functional limitations (OR 2.41; 95% CI 1.71 to 3.41). Subjects with COPD with anxiety had a higher longitudinal risk of COPD exacerbation in Cox proportional hazards analysis after controlling for covariates (HR 1.39; 95% CI 1.007 to 1.90). Conclusion COPD is associated with a higher risk of anxiety. Once anxiety develops among patients with COPD, it is related to poorer health outcomes. Further research is needed to determine whether systematic screening and treatment of anxiety in COPD will improve health outcomes and prevent functional decline and disability.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 46 条
  • [1] Alemayehu B, 2002, VALUE HEALTH, V5, P437
  • [3] [Anonymous], 1987, Am Rev Respir Dis, V136, P1285
  • [4] [Anonymous], 1999, MMWR-MORBID MORTAL W, V48, P993
  • [5] [Anonymous], NATL HLTH INTERVIEW
  • [6] ATS Statement, 2002, Am. J. Respir. Crit. Care Med., V166, P111, DOI [DOI 10.1164/RCCM.166/1/111, DOI 10.1164/AJRCCM.166.1.AT1102]
  • [7] BJELLAND I, 2002, J PSYCHOSOM RES, V0052
  • [8] Occupational exposures and the risk of COPD: dusty trades revisited
    Blanc, P. D.
    Iribarren, C.
    Trupin, L.
    Earnest, G.
    Katz, P. P.
    Balmes, J.
    Sidney, S.
    Eisner, M. D.
    [J]. THORAX, 2009, 64 (01) : 6 - 12
  • [9] International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
    Buist, A. Sonia
    McBurnie, Mary Ann
    Vollmer, William M.
    Gillespie, Suzanne
    Burney, Peter
    Mannino, David M.
    Menezes, Ana M. B.
    Sullivan, Sean D.
    Lee, Todd A.
    Weiss, Kevin B.
    Jensen, Robert L.
    Marks, Guy B.
    Gulsvik, Amund
    Nizankowska-Mogilnicka, Ewa
    [J]. LANCET, 2007, 370 (9589) : 741 - 750
  • [10] Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease - Results from the TORCH study
    Celli, Bartolome R.
    Thomas, Nicola E.
    Anderson, Julie A.
    Ferguson, Gary T.
    Jenkins, Christine R.
    Jones, Paul W.
    Vestbo, Jorgen
    Knobil, Katharine
    Yates, Julie C.
    Calverley, Peter M. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (04) : 332 - 338